鼻のポリプがあるか否かによる慢性鼻炎による個人および社会的経済的負担
Kjell Erik Julius Håkansson1, Steven Arild Wuyts Andersen2, Anders Løkke3,4
1Department of Respiratory Medicine, Copenhagen University Hospital-Hvidovre, 2650 Hvidovre, Denmark.
Medical sciences (Basel, Switzerland)
|February 20, 2026
まとめ
慢性鼻炎 (CRS) は財政に重大な影響を及ぼし,社会に年間数百万ドルの費用がかかります. 患者は,この上部呼吸道疾患のために,より高い医療費と収入の損失に直面します.
科学分野:
- 耳鼻喉科 (Otorhinolaryngology) は,耳鼻喉科 (Otorhinolaryngology) を専門とする医療機関である.
- 健康経済学 医療経済学
- 公衆衛生は公衆衛生である.
背景:
- 慢性鼻炎 (CRS) は,鼻のポリップ (CRSwNP) と鼻のポリップ (CRSsNP) のない形態を含み,公衆衛生上の重大な懸念を代表しています.
- 国内規模でのCRSの経済的影響は,その普及とヘルスケア利用への影響にもかかわらず,ほとんど定量化されていないままです.
研究 の 目的:
- 慢性鼻炎 (CRS) の総合的な国家財政負担を決定する.
- CRSに関連する医療費の過剰,福祉送金,所得の損失を全国の観点から評価する.
主な方法:
- CRS患者の医療,福祉,所得の喪失に関する年間支出データを収集するために,国家データベースを利用した.
- 303,475人のCRS患者の財務データをマッチした健康な個人と比較して,過剰なコストを定量化しました.
- CRS患者をCRSsNPとCRSwNPに分類し,財務的影響の比較分析を行いました.
主要な成果:
- CRS患者の年間医療費の超過は1315ユーロで,年間収入は対照群と比較して1356ユーロ減少した.
- 労働年齢のCRS患者 (18-64歳) は,主に病休と障害により,年間816ユーロの過剰な福祉送金を受けた.
- CRSの社会的負担は686,052,898ユーロと推定され,全身性コルチコステロイド関連疾患は20,332,825ユーロ,過度の福祉移転は年間174,394,048ユーロと推定された.
結論:
- 慢性鼻炎は,医療,福祉,個々の患者の財政を含む,社会に重大な経済的負担を課します.
- 収入の減少と医療利用の増加は,CRSの経済的影響に大きく寄与しています.
- 結論は,CRSの実質的な経済的影響を軽減するための効果的な管理戦略の必要性を強調しています.
関連する概念動画
Chronic Pharyngitis
13.0K
Chronic pharyngitis refers to persistent inflammation of the pharyngial mucosa.
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
Etiology
It often arises from persistent viral or bacterial infections affecting sinuses and tonsils.
Additional contributing factors include inadequate dental hygiene, mouth breathing, recurring tonsillitis, allergic rhinitis, laryngopharyngeal reflux, and exposure to smoke, chemicals, and other environmental pollutants. Allergic reactions to pollen, mold, and pet dander, chronic cough, excessive voice usage,...
13.0K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
Epistaxis
627
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
627
Drugs Used in Upper Respiratory Disorders: Overview
744
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
744


